Literature DB >> 11467308

Retinal imaging techniques in diabetes.

K R Denninghoff1, M H Smith, L Hillman.   

Abstract

Diabetic retinopathy is progressive, and detection early is essential for the prevention of blindness. Doppler flowmetry, retinal photography, scanning laser ophthalmoscopy, and retinal oximetry measurements may identify proliferative disease early. Drawbacks of these methods include lack of compliance, failure to refer, and failure to identify disease early. As a result, diabetic retinopathy is a leading cause of blindness. Our retinal oximeter measures the blood oxygen saturation in the large vessels of the retina near the optic disc. Retinal vessel oxygen saturations measured with our instrument are sensitive indicators of blood loss and hypoxia in swine. We are generating scientific data that suggests that retinal vessel oxygen saturations may be used to identify retinal hypoxia prior to changes in retinal vessel architecture. We expect to study humans within the next two years, and a clinically useful eye oximeter should be available in the near future.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11467308     DOI: 10.1089/152091599316810

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  3 in total

Review 1.  Functional imaging using the retinal function imager: direct imaging of blood velocity, achieving fluorescein angiography-like images without any contrast agent, qualitative oximetry, and functional metabolic signals.

Authors:  David Izhaky; Darin A Nelson; Zvia Burgansky-Eliash; Amiram Grinvald
Journal:  Jpn J Ophthalmol       Date:  2009-09-08       Impact factor: 2.447

2.  Spectroscopic-speckle variance OCT for microvasculature detection and analysis.

Authors:  Xuan Liu; Kang Zhang; Yong Huang; Jin U Kang
Journal:  Biomed Opt Express       Date:  2011-10-04       Impact factor: 3.732

Review 3.  Clinical applications of the retinal functional imager: A brief review.

Authors:  Chaitra Jayadev; Nimesh Jain; Ashwin Mohan; Naresh K Yadav
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.